openPR Logo
Press release

Comprhensive Growth of Endophthalmitis Treatment Market | Pfizer, Celerity Pharmaceuticals, F. Hoffmann-La Roche, Allergan, GlaxoSmithKline, Santen Pharmaceutical , Jina Pharma, Bayer AG

06-05-2019 01:37 PM CET | Health & Medicine

Press release from: persistencemarketresearch.com

Comprhensive Growth of Endophthalmitis Treatment Market |

Endophthalmitis is an inflammatory of the intraocular fluids occurs usually due to infection by fungi, bacteria or parasites during the perioperative period. During infection, photoreceptor cells of the retina often get damaged. Despite surgical intervention and aggressive therapeutics of endophthalmitis treatment, it often results in partial or complete loss of vision loss. Infection in the vitreous cavity results to serious intraocular inflammatory disorders.

Endophthalmitis can be categorized by clinical courses such as acute endophthalmitis and chronic en-dophthalmitis, by etiology as infectious endophthalmitis and non-infectious endophthalmitis and by the causative agents which involved fungi, bacteria, parasites and rare viruses. The most common form of endophthalmitis is acute postoperative endophthalmitis which occurs within 1-2 weeks shortly after ocular surgery. In endogenous endophthalmitis, fungus, gram-positive and gram-negative bacteria are the most frequently caused pathogens.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/27307

Examples of some of the market participants in the global endophthalmitis treatment market identified across the value chain include: Pfizer, Celerity Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd, Al-lergan, GlaxoSmithKline plc, Santen Pharmaceutical Co. Ltd., Jina Pharma, Bayer AG, and Merck Sharp & Dohme Corp.

However, gram-negative bacteria such as Klebsiella pneumoniae are mostly responsible for endoge-nous endophthalmitis cases in East Asia, whereas fungi, gram-positive bacteria are the causative agents that are more prominent in North America and Europe. Endophthalmitis treatment consists of vitrectomy, intravitreal antibiotics, inflammatory drugs and topical therapy. In the case of chronic post-operative endophthalmitis, the diagnostic and treatment approach is very less. Generally only sampling of aqueous humor is done by PCR examination and microbiological culture after which oral therapy is prescribed such as clarithromycin or moxifloxacin for 1 week.

Both these antibiotics work well into the eyes and found to be effective against biofilm formation. If the previous treatment is not successful, intravitreal antibiotics and vitrectomy with posterior capsulotomy are performed. Antibiotics such as Vancomycin, Ceftazidime is mostly given as the first choice of endophthalmitis treatment and Vancomycin and Amikacin are given as the second choice of endophthalmitis treatment. Despite the low incidence of endophthalmitis after intravitreal injections, the high volume usages of these injections has become an increasing factor of infectious exogenous endophthalmitis treatment market. According to NCBI, the incidence rate of post-traumatic endophthalmitis has been accounted to be 0% to 16.5% globally.

Advances in new technology, research and surgical procedures are boosting the endophthalmitis treatment market. For e.g. intravitreal liposomal amphotericin B has been reported effective in the Can-dida endophthalmitis treatment. Nanoparticles coated with daptomycin have been developed as a po-tential topical therapy for bacterial endophthalmitis treatment but still it has not been reported clinically. Pars plana vitrectomy which is indicated for vitreous biopsy, persistent inflammation or retinal complica-tion is mostly used surgical procedure in endophthalmitis treatment.

Get Full TOC @ https://www.persistencemarketresearch.com/toc/27307

The combination of intravitreal antifungal agents and PPV is the most widely used method for fungal endophthalmitis treatment. Due to advancement in vitreoretinal technology, early vitrectomy is widely used surgical procedure for removing the pathogen and at the same time it delivers medication into the posterior segment of the eye which is another factor in driving the endophthalmitis treatment market. Poor prognosis in endophthalmitis treatment and less awareness among people about endophthalmitis ophthalmologist may be the restraining factor in endophthalmitis treatment market.

The global endophthalmitis treatment market is segmented on the basis of medication, types and distri-bution channel.

• Market Segmentation by Medication

o Antibiotics
o Corticosteriods

• Market Segmentation by Types

o Exogenous
 Acute Postoperative
 Chronic Postoperative
 Traumatic
 Filtering Bleb-Associated
 After Intravitreal Injections
o Endogenous

Market Segmentation by Distribution channel

o Hospital pharmacies
o Retail pharmacies
o Ophthalmology Clinics

Geographically, endophthalmitis treatment market is categorized into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is dominating the endoph-thalmitis treatment market due to the increase in cataract surgical procedure and highly developed technologies that lead to a rise in endophthalmitis treatment market. Europe is also boosting the growth of endophthalmitis treatment market due to an increase in the prevalence of endophthalmitis and usage of intracameral antibiotics in the region.

The Asia Pacific is expected to witness fast growth in endophthalmitis treatment market due to the oc-currence of ocular trauma leading to increase in pediatric endophthalmitis treatment and also the rising number of microorganisms which tends to cause the disease is influencing the endophthalmitis treat-ment market. The Middle East and Africa have a slow growth endophthalmitis treatment market due to low adoption of medications endophthalmitis treatment and also fewer government initiatives and awareness among people about endophthalmitis.

Get Full Report @ https://www.persistencemarketresearch.com/market-research/endophthalmitis-treatment-market.asp

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Comprhensive Growth of Endophthalmitis Treatment Market | Pfizer, Celerity Pharmaceuticals, F. Hoffmann-La Roche, Allergan, GlaxoSmithKline, Santen Pharmaceutical , Jina Pharma, Bayer AG here

News-ID: 1765492 • Views:

More Releases from persistencemarketresearch.com

Innovation-Based Discernment To Drive The Foil Shavers Market
Innovation-Based Discernment To Drive The Foil Shavers Market
Personal appearance has taken paramount importance in the lives of consumers. Proper grooming and professional appearance have become important attributes to gain respect at the workplace. The way people carry themselves creates an impression on co-workers and the management. The pressure and interest of looking good is equally important to both, men and women. Variations offered by trimmers and shavers have taken up the onus to drive the foil shavers
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Growth According to 'Persistence Market Research'
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are Haw Par Corporation Limited., Procter & Gamble, GSK group of companies, Amrutanjan Health Care Ltd. and others. The companies are mainly focusing on intense marketing to conve
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia

All 5 Releases


More Releases for Endophthalmitis

The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value. Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete
The Intravitreal (IVT) Injectable Market to grow at a CAGR of 4.9% between 2022- …
The Intravitreal Ivt Injectable Market is bound to reach US$ 23,814.3 Mn at a CAGR of 4.9% between 2018-2028. The current scenario is such that on-demand healthcare storage is being asked for. Cloud computing thus curtails operational expenses and capital as it simplifies sharing medical records, creates and maintains telehealth apps, and automates backend operations. This would be the scene with the healthcare vertical in the upcoming period. According to the
Endophthalmitis Treatment Market to Witness Revolutionary Growth by 2027 | Pfize …
Advance Market Analytics published a new research publication on "Endophthalmitis Treatment Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Endophthalmitis Treatment market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that
FDA Approvals in Full Swing, Prefilled syringes Market Gets a Boost
Prefilled syringes industry has become one of the fastest growing industries in the medical devices sector. Medical professionals have rolled up their sleeves for the optimum utilization of prefilled syringes due to their advantages over traditional vial-based syringes, improved safety & efficiency, and enhanced convenience. The continual advancements in syringe technologies and material have enabled better and safer delivery of drugs, vaccines, therapeutic proteins, and blood stimulants. According to the
Worldwide Analysis on Eye Infection Treatment Market Strategies and Forecasts, 2 …
Eye infection is caused by bacteria, micro-organisms, viruses, and fungi that invade any part of the eye ball and surrounding area which include inner eyelids (conjunctiva), the thin, moist membrane lining the outer eye, and the front surface of the eye (cornea). Eye infections can be the inflammation of the eyelid (blepharitis), conjunctiva (conjunctivitis), the liquid inside the eye (vitritis), the cornea (keratitis), the optic nerve (neuroretinitis) or the retina